The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pandora A/S
CSE:PNDORA
|
DK |
|
F
|
FNS Holdings PCL
SET:FNS
|
TH |
|
Siam Cement PCL
F:TCM
|
TH |
|
A
|
Abcellera Biologics Inc
F:8QQ
|
CA |
|
Top Glove Corporation Bhd
OTC:TPGVF
|
MY |
|
M
|
Mirae Asset Vision Special Purpose Acquisition 5 Co
KOSDAQ:477470
|
KR |
|
Sparc AI Inc
OTC:SPAIF
|
CA |
|
O
|
Oriola Oyj
F:O5O
|
FI |
|
Nexi SpA
F:N0X0
|
IT |
|
M
|
Mitsubishi Motors Corp
DUS:MMO
|
JP |
|
P
|
Panjawattana Plastic PCL
SET:PJW
|
TH |
|
P
|
Platinum Group PCL
SET:PLAT
|
TH |
|
Bank Amar Indonesia Tbk PT
IDX:AMAR
|
ID |
|
Galenica AG
F:G70
|
CH |
|
B
|
Bualuang Office Leasehold Real Estate Investment Trust
SET:B-WORK
|
TH |
|
G
|
GI Innovation Inc
KOSDAQ:358570
|
KR |
|
A
|
Applied DB PCL
SET:ADB
|
TH |
|
H
|
Horseshoe Metals Ltd
SWB:6HS
|
AU |
|
Cerus Corp
NASDAQ:CERS
|
US |
|
A
|
AI Korea Co Ltd
KOSDAQ:364950
|
KR |
|
Newcore Gold Ltd
XTSX:NCAU
|
CA |
|
F
|
Floyd PCL
SET:FLOYD
|
TH |
|
U
|
Union Mosaic Industry PCL
SET:UMI
|
TH |
|
L
|
LabTurbo Biotech Corp
TPEX:7725
|
TW |
Pandora A/S (PNDORA)’s 12-month stock price forecast through October 2027 has a consensus target of kr877.2, implying 3% upside. The forecast is based on price targets from 20 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
PNDORA is 877.2 DKK with a low forecast of 444.4 DKK and a high forecast of 1 050 DKK.
Over the last 13 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 8 years is 4%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 14%. The projected CAGR for the next 8 years is 3%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 8 years is 2%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is -2%.
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 4%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more